Title:
粘液過剰分泌の治療のための組換えボツリヌス菌毒素
Document Type and Number:
Japanese Patent JP4558935
Kind Code:
B2
Abstract:
A method of treating mucus hypersecretion, the causative factor in chronic obstructive pulmonary disease (COPD), asthma and other clinical conditions involving COPD, comprises administering a compound that inhibits exocytosis in mucus secreting cells or neurones that control or direct mucus secretion. Also described is a compound, for use in the treatment of hypersecretion of mucus, which inhibits mucus secretion by inhibiting mucus secreting cells, and/or inhibiting neurotransmitter release from neuronal cells controlling or directing mucus secretion.
Inventors:
Quinn, Conrad Padraig
Foster, Case Alan
John Andrew, Chadock
Foster, Case Alan
John Andrew, Chadock
Application Number:
JP2000565918A
Publication Date:
October 06, 2010
Filing Date:
August 25, 1999
Export Citation:
Assignee:
Syntaxin Limited
International Classes:
A61K9/12; C07K14/33; A61K35/74; A61K38/00; A61K45/00; A61K47/48; A61P11/00; A61P11/06; A61P11/12; A61P43/00; C07K7/06; C07K14/195; C07K14/47; C07K19/00
Domestic Patent References:
| JP9507234A |
Foreign References:
| WO1996033273A1 | ||||
| WO1995028171A1 |
Attorney, Agent or Firm:
Hiromichi Nanjo